Immunity, Inflammation and Disease
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.5 | Q2 | 51.9% | 0.851 | Q2 | 79.3% |
| 2024 | 2.7 | Q3 | 39.7% | 0.814 | Q3 | 78.4% |
| 2023 | 3.1 | Q3 | 39.8% | 0.757 | Q2 | 78.1% |
| 2022 | 3.2 | Q3 | 36.5% | 0.659 | Q3 | 74.9% |
| 2021 | 2.5 | Q4 | 27.1% | 0.562 | Q3 | 70.8% |
| 2020 | — | — | 0.918 | Q2 | 83.3% | |
| 2019 | — | — | 0.865 | Q3 | 82.2% | |
| 2018 | — | — | 0.904 | Q2 | 81.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2050-4527
country
GBcoverage
2013-2026